| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |